Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension

Abstract Background This was a phase 3, randomized, double-blind, placebo-controlled study. Methods Adult Korean patients with essential hypertension and a baseline mean sitting clinic systolic blood pressure (scSBP) ≥150 and ≤180 mmHg were randomized to 6-week treatment with placebo (n = 65), azils...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Attila Juhasz, Jingtao Wu, Michie Hisada, Tomoka Tsukada, Myung Ho Jeong
Format:	Artigo
Jezik:	Inglês
Izdano:	XMLink 2018-02-01
Serija:	Clinical Hypertension
Teme:	Hypertension Azilsartan medoxomil Angiotensin II receptor antagonist Blood pressure Korea
Online dostop:	http://link.springer.com/article/10.1186/s40885-018-0086-4
Oznake:	Označite Brez oznak, prvi označite!